Gene · 8767
Papers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
A necroptosis-related prognostic model for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma based on single-cell sequencing analysis and weighted co-expression network. | Front Genet | 2022 | 36212155 | PubTator, text mining | PubMed |
| Integrated Analyses of m6A Regulator-Based Signature on Its Clinical Application and Immunogenomic Landscape in Stomach Adenocarcinoma. | Biomed Res Int | 2022 | 36193316 | PubTator, text mining | PubMed |
| Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function. | Front Immunol | 2022 | 36189261 | PubTator, text mining | PubMed |
| NOD-like receptors in asthma. | Front Immunol | 2022 | 36189256 | PubTator, text mining | PubMed |
| Mechanism of RIP2 enhancing stemness of glioma cells induces temozolomide resistance. | CNS Neurosci Ther | 2022 | 36184801 | PubTator, text mining | PubMed |
| m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-β-induced epithelial-mesenchymal transition of lung cancer cells. | J Biol Chem | 2022 | 36183833 | PubTator, text mining | PubMed |
| Modulating cholesterol-rich lipid rafts to disrupt influenza A virus infection. | Front Immunol | 2022 | 36177026 | PubTator, text mining | PubMed |
| AntiVIRmiR: A repository of host antiviral miRNAs and their expression along with experimentally validated viral miRNAs and their targets. | Front Genet | 2022 | 36159991 | PubTator, text mining | PubMed |
| Role of Receptor Interacting Protein (RIP) kinases in cancer. | Genes Dis | 2022 | 36157481 | PubTator, text mining | PubMed |
| Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease. | Genome Med | 2022 | 36153599 | PubTator, text mining | PubMed |
| The subversion of toll-like receptor signaling by bacterial and viral proteases during the development of infectious diseases. | Mol Aspects Med | 2022 | 36152458 | PubTator, text mining | PubMed |
| NOD1, NOD2, and NLRC5 Receptors in Antiviral and Antimycobacterial Immunity. | Vaccines (Basel) | 2022 | 36146565 | PubTator, text mining | PubMed |
| Insight into the Relationship between Oral Microbiota and the Inflammatory Bowel Disease. | Microorganisms | 2022 | 36144470 | PubTator, text mining | PubMed |
| The Assessment of Serum Cytokines in Oral Squamous Cell Carcinoma Patients: An Observational Prospective Controlled Study. | J Clin Med | 2022 | 36143043 | PubTator, text mining | PubMed |
| Host Cell Antimicrobial Responses against Helicobacter pylori Infection: From Biological Aspects to Therapeutic Strategies. | Int J Mol Sci | 2022 | 36142852 | PubTator, text mining | PubMed |
| Lactobacillusjohnsonii L531 Protects against Salmonella Infantis-Induced Intestinal Damage by Regulating the NOD Activation, Endoplasmic Reticulum Stress, and Autophagy. | Int J Mol Sci | 2022 | 36142312 | PubTator, text mining | PubMed |
| Recent Advances in PROTACs for Drug Targeted Protein Research. | Int J Mol Sci | 2022 | 36142231 | PubTator, text mining | PubMed |
| mintRULS: Prediction of miRNA-mRNA Target Site Interactions Using Regularized Least Square Method. | Genes (Basel) | 2022 | 36140696 | PubTator, text mining | PubMed |
| Targeted Protein Degradation to Overcome Resistance in Cancer Therapies: PROTAC and N-Degron Pathway. | Biomedicines | 2022 | 36140200 | PubTator, text mining | PubMed |
| Modifiable Innate Biology within the Gut-Brain Axis for Alzheimer's Disease. | Biomedicines | 2022 | 36140198 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8767/papers?page=22